BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19490465)

  • 21. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
    Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
    Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors in follicular carcinoma of the thyroid: a study of 198 cases.
    Rao RS; Parikh HK; Deshmane VH; Parikh DM; Shrikhande SS; Havaldar R
    Head Neck; 1996; 18(2):118-24; discussion 124-6. PubMed ID: 8647676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thyroid gland carcinoma].
    Schmid KW
    Praxis (Bern 1994); 1998 Mar; 87(11):367-74. PubMed ID: 9562812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histological variants (subtypes) of differentiated thyroid carcinoma].
    Abduluakhab M; Mikhaĭlov I; Gavrilov M
    Khirurgiia (Sofiia); 1997; 50(3):31-4. PubMed ID: 9739840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed?
    Dettmer M; Schmitt A; Steinert H; Haldemann A; Meili A; Moch H; Komminoth P; Perren A
    Am J Surg Pathol; 2011 Dec; 35(12):1866-72. PubMed ID: 21989341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas.
    Sakamoto A; Kasai N; Sugano H
    Cancer; 1983 Nov; 52(10):1849-55. PubMed ID: 6313176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological and prognostic analysis of follicular thyroid carcinoma in a single institute over a 15-year period.
    Yu XF; Wang WB; Teng XD; Wang HY; Chen X; Wang HH; Ma ZM; Fahey TJ; Teng LS
    Eur J Surg Oncol; 2014 Jul; 40(7):869-74. PubMed ID: 24613740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.
    Skansing DB; Londero SC; Asschenfeldt P; Larsen SR; Godballe C
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2541-2548. PubMed ID: 28293786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
    Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
    Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Handling of thyroid follicular patterned lesions.
    Rosai J
    Endocr Pathol; 2005; 16(4):279-83. PubMed ID: 16627915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed medullary-follicular and medullary-papillary carcinoma of the thyroid: one or two entities?
    Michal M; Curík R; Macák J; Ludvíková M; Dĕdic K
    Zentralbl Pathol; 1993 Nov; 139(4-5):333-5. PubMed ID: 8130165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid.
    Albores-Saavedra J; Carrick K
    Endocr Pathol; 2004; 15(4):297-305. PubMed ID: 15681853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interpretation of the pathological diagnostic criteria and characteristics of high-grade thyroid follicular-derived carcinoma in the 5
    Zhou J; Liu ZY
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1578-1583. PubMed ID: 38742344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid.
    Volante M; Cavallo GP; Papotti M
    Endocr Pathol; 2004; 15(4):313-7. PubMed ID: 15681855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.
    Ito Y; Miyauchi A
    Endocr J; 2009; 56(2):177-92. PubMed ID: 18703852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
    Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
    Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.
    Xu B; Wang L; Tuttle RM; Ganly I; Ghossein R
    Hum Pathol; 2015 Dec; 46(12):1789-98. PubMed ID: 26482605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma.
    Collini P; Sampietro G; Rosai J; Pilotti S
    Virchows Arch; 2003 Jan; 442(1):71-6. PubMed ID: 12536317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy.
    Heikkilä A; Siironen P; Hagström J; Heiskanen I; Sankila R; Louhimo J; Haglund C; Arola J
    APMIS; 2010 Nov; 118(11):846-54. PubMed ID: 20955457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.